We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A 5-year voluntary scheme on the control of prices agreed between government and the Association of the British Pharmaceutical Industry (ABPI).
Guidance on how to make reasonable adjustments to help support people with learning disabilities in using pharmacy services.
Information for pharmaceutical wholesalers explaining the main changes the Windsor Framework introduces to the packaging for all medicines licensed in the UK, effective from 1 January 2025.
VDEC responds strategically to AMR pathogens and new emerging threats (fungi, viruses, and bacteria), by determining the most appropriate research goals to combat these pathogens
Apply now to join the AI Airlock pilot by the MHRA. Benefit from industry and regulatory expert collaboration, bespoke testing plans, and improved regulatory understanding.
Acceptable naming, presentation and packaging of nicotine-containing electronic cigarettes and refill containers.
A letter providing guidance on the post-transition conversion process was sent by email on 23 October 2020 to the Community MA holders.
Personal protective equipment for sale by the Department of Health and Social Care (DHSC) including visors, gowns, aprons and goggles.
Guidance for hospital blood banks on issuing blood components electronically in line with best practice.
Deficiencies in Omega’s pharmacovigilance system are not thought to affect the safety of the products that they market.
Provide innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
The Defence and Security Accelerator (DASA) is running a Market Exploration to explore the Non-Compressible Haemorrhage (NCH) environment. To understand who is doing work in this area and possible novel solutions of treatmen…
Instructions for integrating with the new production MORE platform API.
Notification Fees for Great Britain and Northern Ireland
Guidance for healthcare professionals on providing free prescriptions for participants in the HEAL-COVID or STIMULATE-ICP long COVID clinical trials.
How to report adverse incidents involving cardiac ablation devices under the vigilance system.
The MHRA has published advice for patients and healthcare professionals
The MHRA is ready to provide any assistance for clinical trials applications submitted for COVID-19
The UK Good Laboratory Practice Monitoring Authority (UK GLPMA) recognises that there are potential challenges COVID-19 will present to members of the GLP monitoring programme.
If pharmacies wish to ‘pack down’ larger packs of a medicinal product, they need to follow these instructions
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).